stockmarketproxy
/
RMDNYSE,OTC SEC EDGAR

RESMED INC

Surgical & Medical Instruments & Apparatus·SAN DIEGO, CA·FY end 06/30·CIK 943819
OverviewFinancialsCompensationGovernanceInsidersFilings

Board of Directors

Director data appears once the latest DEF 14A has been processed through the director-extraction pass.

Risk-factor diff

FY 2025 10-K vs. FY 2024
+96 new84 removed

Net-new paragraphs in the most recent 10-K's Item 1A. Companies rarely add risk language without a real reason — additions here are often a leading signal of management concerns.

NEW · FY 2025

Our inability to compete with new and existing technology to treat OSA successfully may harm our business.

NEW · FY 2025

Global macroeconomic conditions, including the direct and indirect effects of inflation, supply chain disruptions, reciprocal tariffs, and fluctuations in foreign currency exchange rates, could adversely affect our operations and profitability.

NEW · FY 2025

We are subject to new areas of direct healthcare oversight by federal government agencies due to our acquisition of VirtuOx.

NEW · FY 2025

We are increasingly dependent on information technology systems and infrastructure. Failed, substandard or delayed efforts to improve our IT System infrastructure may result in disruption to our business or materially increased costs.

NEW · FY 2025

Our business depends on our ability to market effectively to dealers of home healthcare products, sleep clinics, and physicians.

+ 25 more new paragraphs not shown

Policies & disclosures

Clawback, anti-hedging, stock ownership, and related-party policies will populate from extracted proxy sections.